Efficacy and safety of continuous veno-venous hemofiltration for acute respiratory distress syndrome: a meta-analysis - Report - MDSpire

Assessment of Continuous Veno-Venous Hemofiltration's Safety and Effectiveness in Acute Respiratory Distress Syndrome: A Meta-Analytic Review

  • By

  • Rui Wang

  • Sicheng Xu

  • July 17, 2026

Share

Clinical Report: Assessment of Continuous Veno-Venous Hemofiltration's Safety and Effectiveness in Acute Respiratory Distress Syndrome

Overview

This meta-analysis evaluates the efficacy and safety of continuous veno-venous hemofiltration (CVVH) in patients with acute respiratory distress syndrome (ARDS).

Background

Acute respiratory distress syndrome (ARDS) is a critical condition with high incidence and mortality rates, affecting approximately 3 million patients globally each year. Current treatments have limitations, prompting the exploration of continuous renal replacement therapy (CRRT) modalities, particularly CVVH, as adjunctive therapies for ARDS.

Data Highlights

OutcomeCVVH GroupConventional Treatment GroupP-value
Oxygenation IndexMD = 52.80-p < 0.00001
Mortality RateOR = 0.43-p < 0.00001
ICU DurationMD = -4.88-p < 0.00001
Mechanical Ventilation DurationMD = -4.10-p < 0.00001
APACHE II ScoreMD = -3.62-p < 0.00001

Key Findings

  • CVVH improved the oxygenation index compared to conventional treatment.
  • Mortality rate was lower in the CVVH group (OR = 0.43).
  • ICU hospitalization duration was reduced by an average of 4.88 days with CVVH.
  • Mechanical ventilation duration was shortened by 4.10 days in the CVVH group.
  • CVVH decreased the incidence of ventilator-associated pneumonia (VAP) (OR = 0.21).

Clinical Implications

The findings suggest that CVVH may serve as an effective adjunctive therapy for ARDS, potentially improving patient outcomes. Clinicians should consider the application of CVVH in managing ARDS, particularly in patients with severe cases.

Conclusion

Further large-scale, multicenter randomized controlled trials are necessary to validate these findings.

Related Resources & Content

  1. Critical Care (Springer), 2025 -- Diagnostic performance of a 250-ml net ultrafiltration challenge to identify risk of preload-dependence in critically ill patients undergoing continuous renal replacement therapy: a randomized, cross-over trial
  2. Intensive Care Medicine, 2010 -- Review of Key Developments in Intensive Care Medicine for 2009: Focus on Mechanical Ventilation, Acute Lung Injury, Respiratory Distress Syndrome, Pediatric Considerations, Ethical Issues, and Additional Topics
  3. Intensive Care Medicine, 2025 -- Evaluation of Two Bicarbonate Replacement Solutions in Continuous Veno-Venous Hemofiltration with Regional Citrate Anticoagulation: A Prospective, Randomized, Controlled Study
  4. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline - PMC
  5. New Insights on Continuous Renal Replacement Therapy for Acute Respiratory Distress Syndrome: A Systematic Review and Meta‐Analysis - PMC
  6. Intensive Care Medicine — Comparison of Hemodynamic Monitoring and Standard Care for Fluid Balance Management in Acute Circulatory Failure Patients Undergoing Continuous Renal Replacement Therapy: Findings from the GO NEUTRAL Randomized Controlled Trial
  7. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline - PMC
  8. New Insights on Continuous Renal Replacement Therapy for Acute Respiratory Distress Syndrome: A Systematic Review and Meta‐Analysis - PMC
  9. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 - PMC

Original Source(s)

Related Content